| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $17.4M | -32.4% |
| R&D Expense | $50.3M | +18.0% |
| SG&A Expense | $108.7M | +141.8% |
| Operating Income | -$143.2M | -128.3% |
| Interest Expense | $3.3M | +52.2% |
| Pre-tax Income | -$135.9M | -118.8% |
| Income Tax | $0 | +100.0% |
| Net Income | -$135.9M | -118.9% |
| EPS (Basic) | -$4.62 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $224.9M | +213.9% |
| Short-term Investments | $2.5M | -98.3% |
| Accounts Receivable | $16.6M | — |
| Inventory | $3.1M | — |
| Current Assets | $256.1M | +13.6% |
| Total Assets | $265.5M | +16.5% |
| Current Liabilities | $36.9M | +139.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$117.5M | -139.6% |
| Capital Expenditures | $1.5M | +196.8% |
| Investing Cash Flow | $140.6M | +197.2% |
| Financing Cash Flow | $130.2M | +38.5% |
| Free Cash Flow | -$119.0M | -140.2% |
| -83.3% |
| EPS (Diluted) | -$4.62 | -83.3% |
| Long-term Debt |
| $29.8M |
| +53.4% |
| Total Liabilities | $68.5M | +95.9% |
| Stockholders' Equity | $197.0M | +2.1% |